pharmacychecker.com LLC v. Legitscript LLC

Plain English (For Everyone)

A company called Legitscript created a program that limits which prescription drugs pharmacies can advertise. A competitor, PharmacyChecker, sued, claiming this was an illegal business practice. The court ruled against PharmacyChecker, stating that Legitscript acted alone and didn't conspire with others, so there was no violation of antitrust law.

For Legal Practitioners

The Ninth Circuit affirmed dismissal of PharmacyChecker's Section 1 Sherman Act claim, holding that the plaintiff failed to plausibly allege an agreement. Legitscript's unilateral implementation of a certification program restricting pharmacy advertising of certain drugs, without more, does not constitute a conspiracy. The court emphasized the need for factual allegations demonstrating a 'conscious commitment to a common scheme.'

For Law Students

This case illustrates the 'agreement' element required for a Section 1 Sherman Act claim. PharmacyChecker alleged an unlawful restraint of trade based on Legitscript's certification program. However, the Ninth Circuit found that PharmacyChecker did not adequately plead a conspiracy, as Legitscript's actions were unilateral, thus affirming dismissal.

Newsroom Summary

A federal appeals court has sided with Legitscript in an antitrust dispute, ruling that the company's program restricting pharmacy advertising of certain drugs did not violate the law. The court found that Legitscript acted independently and did not conspire with others, a key requirement for such claims.

Standard of Review

De novo review. The Ninth Circuit reviews de novo a district court's dismissal of a complaint for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). This means the appellate court examines the complaint and the relevant law without giving deference to the district court's decision.

Procedural Posture

The case reached the Ninth Circuit on appeal from the United States District Court for the District of Arizona, which had dismissed PharmacyChecker's antitrust claims against Legitscript.

Burden of Proof

The burden of proof was on PharmacyChecker to plausibly allege facts demonstrating an unlawful restraint of trade under Section 1 of the Sherman Act. The standard required more than mere allegations; it demanded specific facts showing an agreement or conspiracy.

Legal Tests Applied

Statutory References

Key Legal Definitions

Rule Statements

To state a claim under Section 1 of the Sherman Act, a plaintiff must allege facts that tend to show that the defendant and some other person or entity have a conscious commitment to a common scheme or an unlawful design.

A plaintiff must allege facts that show that the defendant and some other person or entity have a conscious commitment to a common scheme or an unlawful design.

The "agreement" element of a Section 1 claim requires more than just parallel conduct; it requires evidence of a conspiracy or agreement.

Judges

• Richard A. Paez
• Marsha S. Berzon
• Michelle T. Friedland

Scenario: A company implements a new policy that affects how its business partners can advertise or operate, and a competitor believes this policy is anticompetitive.

Your Rights: You have the right to compete fairly, but you must be able to prove that a competitor's actions involve an agreement or conspiracy with others to unlawfully restrain trade, not just independent business decisions.

What To Do: If you believe a competitor's actions are anticompetitive, consult with an antitrust attorney. You will need to gather evidence showing not just the competitor's actions, but also proof of an agreement or conspiracy with other parties.

Is it legal for a company to create a certification program that restricts how other businesses advertise?

Depends. If the company acts unilaterally and the program does not involve an agreement or conspiracy with others to restrain trade, it is likely legal. However, if the program is part of a larger conspiracy to fix prices, limit competition, or engage in other anticompetitive conduct, it could be illegal under antitrust laws like the Sherman Act.

This applies to federal antitrust law in the United States.

For Online pharmacies and drug manufacturers

Companies that implement certification or vetting programs that restrict advertising or sales of certain products must ensure their actions are unilateral and not part of an agreement with competitors. Otherwise, they risk antitrust challenges. Conversely, competitors harmed by such programs must be prepared to demonstrate an actual conspiracy, not just the existence of the program itself.

For Antitrust regulators and enforcers

This ruling reinforces the distinction between unilateral conduct and concerted action under Section 1 of the Sherman Act. Regulators must present evidence of an agreement to successfully challenge such practices under Section 1.

Q: What is pharmacychecker.com LLC v. Legitscript LLC about?

pharmacychecker.com LLC v. Legitscript LLC is a case decided by Ninth Circuit on May 23, 2025.

Q: What court decided pharmacychecker.com LLC v. Legitscript LLC?

pharmacychecker.com LLC v. Legitscript LLC was decided by the Ninth Circuit, which is part of the federal judiciary. This is a federal appellate court.

Q: When was pharmacychecker.com LLC v. Legitscript LLC decided?

pharmacychecker.com LLC v. Legitscript LLC was decided on May 23, 2025.

Q: What is the citation for pharmacychecker.com LLC v. Legitscript LLC?

The citation for pharmacychecker.com LLC v. Legitscript LLC is 137 F.4th 1031. Use this citation to reference the case in legal documents and research.

Q: What was the main issue in PharmacyChecker.com LLC v. Legitscript LLC?

The main issue was whether Legitscript's certification program, which restricted pharmacies from advertising certain prescription drugs, constituted an unlawful restraint of trade under Section 1 of the Sherman Act. PharmacyChecker alleged an antitrust violation, but the court focused on whether there was an agreement.

Q: What is the role of the Federal Trade Commission (FTC) in antitrust cases?

The FTC, along with the Department of Justice's Antitrust Division, enforces antitrust laws. They can investigate and bring cases against companies for anticompetitive practices, though this specific case was a private lawsuit.

Q: Is pharmacychecker.com LLC v. Legitscript LLC published?

pharmacychecker.com LLC v. Legitscript LLC is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What was the ruling in pharmacychecker.com LLC v. Legitscript LLC?

The court ruled in favor of the defendant in pharmacychecker.com LLC v. Legitscript LLC. Key holdings: The court held that PharmacyChecker failed to plausibly allege a conspiracy or agreement to restrain trade, a necessary element for a Section 1 Sherman Act claim, as Legitscript's actions were unilateral.; The court found that Legitscript's certification program, which requires pharmacies to meet certain standards to advertise prescription drugs, did not constitute an unlawful restraint of trade because it was a unilateral decision by Legitscript.; The court determined that PharmacyChecker did not adequately plead the existence of an agreement between Legitscript and any other entity that would support an antitrust claim.; The court rejected PharmacyChecker's argument that Legitscript's actions were per se illegal, finding that the alleged conduct did not fall into a category of agreements that are automatically deemed unreasonable.; The court affirmed the dismissal of the complaint, concluding that PharmacyChecker had not stated a claim upon which relief could be granted under the Sherman Act..

Q: Why is pharmacychecker.com LLC v. Legitscript LLC important?

pharmacychecker.com LLC v. Legitscript LLC has an impact score of 30/100, indicating limited broader impact. This decision reinforces the high pleading standard for antitrust claims, particularly those alleging a Section 1 Sherman Act violation. It clarifies that unilateral actions, even if they have anticompetitive effects, are not sufficient to establish an unlawful conspiracy. Businesses operating certification or standard-setting programs should take note of the importance of documenting the unilateral nature of their decisions.

Q: What precedent does pharmacychecker.com LLC v. Legitscript LLC set?

pharmacychecker.com LLC v. Legitscript LLC established the following key holdings: (1) The court held that PharmacyChecker failed to plausibly allege a conspiracy or agreement to restrain trade, a necessary element for a Section 1 Sherman Act claim, as Legitscript's actions were unilateral. (2) The court found that Legitscript's certification program, which requires pharmacies to meet certain standards to advertise prescription drugs, did not constitute an unlawful restraint of trade because it was a unilateral decision by Legitscript. (3) The court determined that PharmacyChecker did not adequately plead the existence of an agreement between Legitscript and any other entity that would support an antitrust claim. (4) The court rejected PharmacyChecker's argument that Legitscript's actions were per se illegal, finding that the alleged conduct did not fall into a category of agreements that are automatically deemed unreasonable. (5) The court affirmed the dismissal of the complaint, concluding that PharmacyChecker had not stated a claim upon which relief could be granted under the Sherman Act.

Q: What are the key holdings in pharmacychecker.com LLC v. Legitscript LLC?

1. The court held that PharmacyChecker failed to plausibly allege a conspiracy or agreement to restrain trade, a necessary element for a Section 1 Sherman Act claim, as Legitscript's actions were unilateral. 2. The court found that Legitscript's certification program, which requires pharmacies to meet certain standards to advertise prescription drugs, did not constitute an unlawful restraint of trade because it was a unilateral decision by Legitscript. 3. The court determined that PharmacyChecker did not adequately plead the existence of an agreement between Legitscript and any other entity that would support an antitrust claim. 4. The court rejected PharmacyChecker's argument that Legitscript's actions were per se illegal, finding that the alleged conduct did not fall into a category of agreements that are automatically deemed unreasonable. 5. The court affirmed the dismissal of the complaint, concluding that PharmacyChecker had not stated a claim upon which relief could be granted under the Sherman Act.

Q: What cases are related to pharmacychecker.com LLC v. Legitscript LLC?

Precedent cases cited or related to pharmacychecker.com LLC v. Legitscript LLC: Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007); Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574 (1986); Federal Trade Comm'n v. Superior Court Trial Lawyers Ass'n, 493 U.S. 411 (1990); Texaco Inc. v. Dagher, 547 U.S. 806 (2006).

Q: What is Section 1 of the Sherman Act?

Section 1 of the Sherman Act prohibits contracts, combinations, or conspiracies that unreasonably restrain trade. To win a case under this section, a plaintiff must prove that there was an agreement between two or more parties.

Q: Did the court find that Legitscript violated antitrust law?

No, the Ninth Circuit affirmed the dismissal of PharmacyChecker's claims. The court found that PharmacyChecker failed to adequately plead that Legitscript's actions involved an agreement or conspiracy, which is a necessary element for a Section 1 Sherman Act claim.

Q: What does 'unilateral action' mean in this context?

Unilateral action means that Legitscript acted on its own, without any agreement or coordination with other companies. The court determined that Legitscript's certification program was a unilateral decision, and unilateral actions generally do not violate Section 1 of the Sherman Act.

Q: What does 'plausibly allege' mean for a legal claim?

To 'plausibly allege' means that the facts presented in a complaint must be specific enough to suggest that the claim is more than just a possibility. The court must be able to infer that the alleged conduct is likely true, not just a hypothetical scenario.

Q: What kind of evidence is needed to prove a conspiracy under the Sherman Act?

To prove a conspiracy, a plaintiff needs to show a 'conscious commitment to a common scheme or an unlawful design.' This requires more than just showing that companies acted similarly; it requires evidence of an actual agreement or collusion.

Q: Can a company be sued for creating a program that harms its competitors?

Yes, but only if the program is part of an illegal agreement or conspiracy to restrain trade. If the company acts independently, even if its actions negatively impact competitors, it generally does not violate antitrust laws like Section 1 of the Sherman Act.

Q: Are there any exceptions for legitimate business practices that might seem to restrain trade?

Yes, the 'rule of reason' allows for restraints on trade that are reasonably necessary to achieve a legitimate business purpose and do not unduly harm competition. However, practices like price-fixing are illegal per se.

Q: What is the difference between Section 1 and Section 2 of the Sherman Act?

Section 1 addresses agreements that restrain trade, while Section 2 addresses monopolization and attempts to monopolize. This case specifically dealt with Section 1's requirement of an agreement.

Q: What is the significance of the 'conscious commitment to a common scheme' standard?

This standard means that for a Section 1 claim to succeed, the plaintiff must show that the parties involved intentionally worked together towards an unlawful goal. It prevents liability for actions that might appear similar but are independently motivated.

Q: Can a company sue for damages if it proves an antitrust violation?

Yes, under the Clayton Act, private parties who prove they were harmed by an antitrust violation can sue for treble damages (three times their actual damages), plus costs and attorney fees.

Q: What is the difference between a 'contract, combination, or conspiracy' under Section 1?

These terms are often used interchangeably, but they all refer to some form of agreement or concerted action between separate entities. The key is that it's not a unilateral action by a single entity.

Q: How does pharmacychecker.com LLC v. Legitscript LLC affect me?

This decision reinforces the high pleading standard for antitrust claims, particularly those alleging a Section 1 Sherman Act violation. It clarifies that unilateral actions, even if they have anticompetitive effects, are not sufficient to establish an unlawful conspiracy. Businesses operating certification or standard-setting programs should take note of the importance of documenting the unilateral nature of their decisions. As a decision from a federal appellate court, its reach is national. This case is moderate in legal complexity to understand.

Q: What happens if a company's actions are found to be a conspiracy in restraint of trade?

If a company's actions are found to be a conspiracy in restraint of trade under Section 1 of the Sherman Act, they can face significant penalties, including substantial fines, injunctions, and potential treble damages awarded to injured parties.

Q: What should a business do if it wants to implement a new policy that might affect competitors?

A business should consult with legal counsel specializing in antitrust law to ensure the policy is structured as a unilateral business decision and does not inadvertently create the appearance of or actual agreement with other entities.

Q: What should a business owner do if they believe a competitor is engaging in anticompetitive behavior?

Gather specific evidence of an agreement or conspiracy between the competitor and other parties. Consult with an antitrust attorney to assess whether the evidence supports a claim under antitrust laws like the Sherman Act.

Q: What is the historical context of the Sherman Act?

The Sherman Antitrust Act was passed in 1890 to combat the growing power of large trusts and monopolies that were seen as harmful to consumers and smaller businesses, aiming to promote free and open markets.

Q: How has the interpretation of 'agreement' in antitrust law evolved?

Courts have consistently required proof of a 'meeting of the minds' or a 'conscious commitment to a common scheme' for Section 1 claims. The interpretation has focused on distinguishing between independent actions and concerted action.

Q: What was the docket number in pharmacychecker.com LLC v. Legitscript LLC?

The docket number for pharmacychecker.com LLC v. Legitscript LLC is 24-2697. This identifier is used to track the case through the court system.

Q: Can pharmacychecker.com LLC v. Legitscript LLC be appealed?

Potentially — decisions from federal appellate courts can be appealed to the Supreme Court of the United States via a petition for certiorari, though the Court accepts very few cases.

Q: What is the standard of review for this type of case?

The Ninth Circuit reviewed the district court's dismissal de novo. This means the appellate court examined the case and the law independently, without giving deference to the lower court's decision.

Q: How did the case reach the Ninth Circuit?

The case came to the Ninth Circuit on appeal after the United States District Court for the District of Arizona dismissed PharmacyChecker's antitrust claims against Legitscript.